An Investigator-Initiated Study to Assess the Association of Diabetic Retinopathy Severity Scale (DRSS) With Level of Decreased Corneal Sensitivity
NCT05566717 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2022-10-04
Summary
Evaluate the association between level of decreased corneal sensitivity and diabetic retinopathy severity scale
Conditions
Sponsors & Collaborators
-
Oyster Point Pharma, Inc.
collaborator INDUSTRY -
Medical Center Ophthalmology Associates
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-01
- Primary Completion
- 2022-09-30
- Completion
- 2022-10-31
Countries
- United States
Study Locations
More Related Trials
-
Specular Microscopy in Patients With Proliferative Diabetic Retinopathy
NCT05838898 ·Status: UNKNOWN
-
INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study
NCT04505566 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Blood Factors and Diabetic Retinopathy
NCT00005761 ·Status: COMPLETED
-
Pivotal Trial to Assess the Clinical Performance of Ophthal-360 for the Detection of Diabetic Retinopathy
NCT05806957 ·Status: UNKNOWN
-
Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy
NCT05393284 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Observational Study to Assess Genotypes/Phenotypes Correlations in Type-2 Diabetic Retinopathy
NCT01228981 ·Status: COMPLETED
-
Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
NCT00248131 ·Status: TERMINATED ·Phase: PHASE3
-
Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes
NCT07270133 ·Status: NOT_YET_RECRUITING
-
Topical Application of Latanoprost in Diabetic Retinopathy
NCT01225653 ·Status: COMPLETED ·Phase: PHASE4
-
Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)
NCT05383209 ·Status: COMPLETED ·Phase: PHASE2
-
Diabetic Retinopathy and Visual Function Study
NCT00001346 ·Status: COMPLETED
-
Automated AI-based System for Early Diagnosis of Diabetic Retinopathy
NCT05324189 ·Status: UNKNOWN
-
Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)
NCT00001612 ·Status: COMPLETED
-
Exploring the Interaction Between Metabolic Disorders and NLPR3 Inflammasome Activation in DR Inflammatory Damage
NCT06272565 ·Status: NOT_YET_RECRUITING
-
Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens
NCT02587741 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy
NCT02307110 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)
NCT05066230 ·Status: TERMINATED ·Phase: PHASE3
-
To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR
NCT07230184 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Decision Support Algorithm to Predict Diabetic Retinopathy
NCT03769948 ·Status: UNKNOWN
-
Study Investigating the Levels and Effects of Low-grade Inflammation in Diabetic Retinopathy of Type 1 Diabetes
NCT00880139 ·Status: TERMINATED
-
Effect of Argon Laser Panretinal Photocoagulation on Corneal Endothelial Cell Density .
NCT07157553 ·Status: NOT_YET_RECRUITING
-
Pharmacological Intervention in Diabetic Retinopathy
NCT00619034 ·Status: COMPLETED ·Phase: NA
-
Fenofibrate for Prevention of DR Worsening
NCT04661358 ·Status: RECRUITING ·Phase: PHASE3
-
Diabetic Retinopathy Functional Evaluation Study: Monitoring Carotenoid Vitamins Treatment Using ERG
NCT04117022 ·Status: UNKNOWN ·Phase: NA
-
Serum and Intraocular Levels of Erythropoietin and VEGF in Type 2 Diabetes Patients With Proliferative Retinopathy
NCT01871207 ·Status: COMPLETED